Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts

BACKGROUND: Expression of miR-17-92 enhances T-cell survival and interferon (IFN)-γ production. We previously reported that miR-17-92 is down-regulated in T-cells derived from glioblastoma (GBM) patients. We hypothesized that transgene-derived co-expression of miR17-92 and chimeric antigen receptor...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ohno, Masasuke, Ohkuri, Takayuki, Kosaka, Akemi, Tanahashi, Kuniaki, June, Carl H, Natsume, Atsushi, Okada, Hideho
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2013
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4019893/
https://ncbi.nlm.nih.gov/pubmed/24829757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-1-21
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items